109 related articles for article (PubMed ID: 14975604)
1. Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression.
Matesanz F; Fedetz M; Leyva L; Delgado C; Fernández O; Alcina A
J Neuroimmunol; 2004 Mar; 148(1-2):212-7. PubMed ID: 14975604
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis.
Weber A; Wandinger KP; Mueller W; Aktas O; Wengert O; Grundström E; Ehrlich S; Windemuth C; Kuhlmann T; Wienker T; Brück W; Zipp F
J Neuroimmunol; 2004 Apr; 149(1-2):195-201. PubMed ID: 15020080
[TBL] [Abstract][Full Text] [Related]
3. The -431C>T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients.
Tsunemi Y; Komine M; Sekiya T; Saeki H; Nakamura K; Hirai K; Kakinuma T; Kagami S; Fujita H; Asano N; Tanida Y; Wakugawa M; Torii H; Tamaki K
Exp Dermatol; 2004 Nov; 13(11):715-9. PubMed ID: 15500644
[TBL] [Abstract][Full Text] [Related]
4. Sex specifically associated promoter polymorphism in multiple sclerosis affects interleukin 4 expression levels.
Akkad DA; Arning L; Ibrahim SM; Epplen JT
Genes Immun; 2007 Dec; 8(8):703-6. PubMed ID: 17855802
[TBL] [Abstract][Full Text] [Related]
5. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
Sayad A
Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
[TBL] [Abstract][Full Text] [Related]
6. Divergence of ape and human monoamine oxidase A gene promoters: comparative analysis of polymorphisms, tandem repeat structures and transcriptional activities on reporter gene expression.
Inoue-Murayama M; Mishima N; Hayasaka I; Ito S; Murayama Y
Neurosci Lett; 2006 Sep; 405(3):207-11. PubMed ID: 16890352
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis.
Kroner A; Mäurer M; Loserth S; Kleinschnitz C; Hemmer B; Rosche B; Toyka KV; Rieckmann P
Tissue Antigens; 2004 Jul; 64(1):70-3. PubMed ID: 15191525
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis.
Osoegawa M; Miyagishi R; Ochi H; Nakamura I; Niino M; Kikuchi S; Murai H; Fukazawa T; Minohara M; Tashiro K; Kira J
J Neuroimmunol; 2005 Apr; 161(1-2):195-8. PubMed ID: 15748960
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the in vitro transcriptional activity of polymorphic alleles of the human monoamine oxidase-B gene.
Costa-Mallen P; Kelada SN; Costa LG; Checkoway H
Neurosci Lett; 2005 Jul 22-29; 383(1-2):171-5. PubMed ID: 15936531
[TBL] [Abstract][Full Text] [Related]
10. TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells.
Kakuta Y; Ueki N; Kinouchi Y; Negoro K; Endo K; Nomura E; Takagi S; Takahashi S; Shimosegawa T
Hum Mol Genet; 2009 Mar; 18(6):1089-98. PubMed ID: 19124533
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population.
Tajouri L; Ferreira L; Ovcaric M; Curtain R; Lea R; Csurhes P; Pender MP; Griffiths LR
J Neurol Sci; 2004 Mar; 218(1-2):25-8. PubMed ID: 14759629
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
[TBL] [Abstract][Full Text] [Related]
13. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression.
Schedel M; Frei R; Bieli C; Cameron L; Adamski J; Lauener R; Kabesch M
J Allergy Clin Immunol; 2009 Sep; 124(3):583-9, 589.e1-6. PubMed ID: 19665768
[TBL] [Abstract][Full Text] [Related]
14. Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter.
Wang W; Jaiswal AK
Free Radic Biol Med; 2004 Oct; 37(8):1231-43. PubMed ID: 15451063
[TBL] [Abstract][Full Text] [Related]
15. Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.
Kantarci OH; Hebrink DD; Schaefer-Klein J; Sun Y; Achenbach S; Atkinson EJ; Heggarty S; Cotleur AC; de Andrade M; Vandenbroeck K; Pelfrey CM; Weinshenker BG
Arch Neurol; 2008 Mar; 65(3):349-57. PubMed ID: 18332247
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
17. Expression of the SLC11A1 (NRAMP1) 5'-(GT)n repeat: opposite effect in the presence of -237C-->T.
Zaahl MG; Robson KJ; Warnich L; Kotze MJ
Blood Cells Mol Dis; 2004; 33(1):45-50. PubMed ID: 15223010
[TBL] [Abstract][Full Text] [Related]
18. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
[TBL] [Abstract][Full Text] [Related]
19. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression.
Hranilovic D; Stefulj J; Schwab S; Borrmann-Hassenbach M; Albus M; Jernej B; Wildenauer D
Biol Psychiatry; 2004 Jun; 55(11):1090-4. PubMed ID: 15158428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
